Adam Wieschhaus, PhD, CFA
Principal, Northpond Ventures
Adam is a Principal at Northpond Ventures out of the San Francisco office. Prior to joining Northpond Ventures, he was a Vice President at Cowen and Company, where he covered the life science tools and diagnostics space for six years. Previously, he conducted his postdoctoral studies at Tufts Medical School, where he developed and refined drug candidates across several therapeutic areas. He holds a PhD from the University of Illinois College of Medicine, a BS in biochemistry and molecular biology from the University of Georgia, and is a CFA charterholder.